glp-1 weight loss comparison chart With so much chatter about drugs everywhere right now, it's hard to believe that Ozempic only came on the scene in 2017 to treat type 2 diabetes. It wasn't until 2021 No Magic Little Pill: GLP1's

As mentioned above, 70% of diabetes patients discontinue GLP-1 treatment within two years

Weekly Formulations GLP-1 medications come in both daily and weekly formulations, offering flexibility to suit different preferences and lifestyles

To date, the SURPASS program includes nine ongoing randomized controlled trials in patients with type2 diabetes: SURPASS 1 in monotherapy, SURPASS 2 versus semaglutide, SURPASS 3 versus degludec, SURPASS 4 versus glargine and established CV disease, SURPSS 5 basal insulin add-on, SURPASS AP- Combo versus glargine, and SURPASS-CVOT

In diabetic kidney disease patients, a reduction in insulin levels, albuminuria, and the progression of renal failure were observed as a GLP-1R effect [56, 57]

The platform's pricing and convenience make it accessible to people who might otherwise not have access to these medications